Therapeutic strategies for spinal muscular atrophy: SMN and beyond

Therapeutic strategies for spinal muscular atrophy: SMN and beyond

Toon andere (1) versies

Spinal muscular atrophy (SMA) is a devastating neuromuscular disorder characterized by loss of motor neurons and muscle atrophy, generally presenting in childhood. SMA is caused by low levels of the survival motor neuron protein (SMN) due to inactivating mutations in the encoding gene SMN1. A second...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Bowerman, M, Becker, C, Yáñez-Muñoz, R, Ning, K, Wood, M, Gillingwater, T, Talbot, K, UK SMA Research Consortium
Formaat:	Journal article
Gepubliceerd in:	Company of Biologists 2017

Gelijkaardige items

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
door: Bowerman, M, et al.
Gepubliceerd in: (2017)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
door: Melissa Bowerman, et al.
Gepubliceerd in: (2017-08-01)

Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
door: Winkelsas, AM, et al.
Gepubliceerd in: (2021)

Targeting the 5′ untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
door: Audrey M. Winkelsas, et al.
Gepubliceerd in: (2021-03-01)

SMN deficiency disrupts brain development in a mouse model of severe spinal muscular atrophy.
door: Wishart, T, et al.
Gepubliceerd in: (2010)

Spinal muscular atrophy: antisense oligonucleotide therapy opens the door to an integrated therapeutic landscape
door: Wood, M, et al.
Gepubliceerd in: (2017)

SMN post-translational modifications in spinal muscular atrophy
door: Giulietta M. Riboldi, et al.
Gepubliceerd in: (2023-02-01)

Spinal muscular atrophy in Venezuela: quantitative analysis of SMN1 and SMN2 genes
door: Yuri Yépez, et al.
Gepubliceerd in: (2020-06-01)

Molecular Crosstalk Between Non-SMN-Related and SMN-Related Spinal Muscular Atrophy
door: Darija Šoltić, et al.
Gepubliceerd in: (2020-03-01)

The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy.
door: Sleigh, J, et al.
Gepubliceerd in: (2011)

Therapy Development for Spinal Muscular Atrophy in SMN Independent Targets
door: Li-Kai Tsai
Gepubliceerd in: (2012-01-01)

CORRIGENDUM to Molecular Crosstalk Between Non-SMN-Related and SMN-Related Spinal Muscular Atrophy
Gepubliceerd in: (2020-04-01)

The Need for SMN-Independent Treatments of Spinal Muscular Atrophy (SMA) to Complement SMN-Enhancing Drugs
door: Niko Hensel, et al.
Gepubliceerd in: (2020-02-01)

Restoring SMN Expression: An Overview of the Therapeutic Developments for the Treatment of Spinal Muscular Atrophy
door: Tejal Aslesh, et al.
Gepubliceerd in: (2022-01-01)

SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy
door: Valeria Valsecchi, et al.
Gepubliceerd in: (2023-11-01)

The spinal muscular atrophy disease protein SMN is linked to the Golgi network.
door: Chen-Hung Ting, et al.
Gepubliceerd in: (2012-01-01)

In Vivo Translatome Profiling in Spinal Muscular Atrophy Reveals a Role for SMN Protein in Ribosome Biology
door: Paola Bernabò, et al.
Gepubliceerd in: (2017-10-01)

Patient-specific responses to SMN2 splice-modifying treatments in spinal muscular atrophy fibroblasts
door: Ilaria Signoria, et al.
Gepubliceerd in: (2024-12-01)

Quantitative and structural features of the SMN1 and SMN2 genes in patients with spinal muscular atrophy 5q
door: A. I. Vlasenko, et al.
Gepubliceerd in: (2024-12-01)

A single amino acid residue regulates PTEN-binding and stability of the spinal muscular atrophy protein SMN
door: Rademacher, S, et al.
Gepubliceerd in: (2020)

Spinal muscular atrophy.
door: Talbot, K, et al.
Gepubliceerd in: (2001)

Targeting SR proteins improves SMN expression in spinal muscular atrophy cells.
door: Claribel D Wee, et al.
Gepubliceerd in: (2014-01-01)

The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy
door: James N. Sleigh, et al.
Gepubliceerd in: (2011-07-01)

Molecular and Epidemiological Characterization of SMN Genes in Cuban Patients with Spinal Muscular Atrophy
door: Fabián Lombillo-Alfonso, et al.
Gepubliceerd in: (2020-01-01)

Molecular And Epidemiological Characterization Of SMN Genes In Cuban Patients With Spinal Muscular Atrophy
door: Fabián Lombillo, et al.
Gepubliceerd in: (2019-05-01)

What could be the function of the spinal muscular atrophy-causing protein SMN in macrophages?
door: Ines Tapken, et al.
Gepubliceerd in: (2024-05-01)

Development and Translation of Therapies for Spinal Muscular Atrophy
door: Hannah K. Shorrock, et al.
Gepubliceerd in: (2016-07-01)

Review: neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy.
door: Murray, L, et al.
Gepubliceerd in: (2010)

Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
door: Winkelsas, AM
Gepubliceerd in: (2020)

Abnormal motor phenotype in the SMNΔ7 mouse model of spinal muscular atrophy
door: Matthew E.R. Butchbach, et al.
Gepubliceerd in: (2007-08-01)

A Single Amino Acid Residue Regulates PTEN-Binding and Stability of the Spinal Muscular Atrophy Protein SMN
door: Sebastian Rademacher, et al.
Gepubliceerd in: (2020-11-01)

The neuromuscular impact of symptomatic SMN restoration in a mouse model of spinal muscular atrophy
door: W. Arnold, et al.
Gepubliceerd in: (2016-03-01)

Gene therapy for spinal muscular atrophy: perspectives on the possibility of optimizing SMN1 delivery to correct all neurological and systemic perturbations
door: Sharon J. Brown, et al.
Gepubliceerd in: (2025-07-01)

Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy
door: Niba, Emma Tabe Eko, et al.
Gepubliceerd in: (2022)

Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy
door: Niba, Emma Tabe Eko, et al.
Gepubliceerd in: (2022)

P719: SMN1 deletion and silent carrier screening for spinal muscular atrophy
door: Poh San Lai, et al.
Gepubliceerd in: (2024-01-01)

Investigation of a recombinant SMN protein delivery system to treat spinal muscular atrophy
door: Anderton Ryan, et al.
Gepubliceerd in: (2014-03-01)

Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes
door: Amparo Garcia-Lopez, et al.
Gepubliceerd in: (2018-05-01)

Analysis of the survival of motor neuron (SMN1) gene mutations in Spinal Muscular Atrophy through models
door: Owen, N, et al.
Gepubliceerd in: (2002)

Chapter 16 Spinal Muscular Atrophy
door: Talbot, K, et al.
Gepubliceerd in: (2003)